Page last updated: 2024-08-23

lovastatin and Cerebral Malaria

lovastatin has been researched along with Cerebral Malaria in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Canavese, M; Crisanti, A1
Assis, EF; Bozza, FA; Bozza, PT; Castro-Faria-Neto, HC; d'Avila, JC; da Silva, TI; Estato, V; Reis, PA; Siqueira, LD; Tibiriça, EV; Zimmerman, GA1

Other Studies

2 other study(ies) available for lovastatin and Cerebral Malaria

ArticleYear
Vascular endothelial growth factor (VEGF) and lovastatin suppress the inflammatory response to Plasmodium berghei infection and protect against experimental cerebral malaria.
    Pathogens and global health, 2015, Volume: 109, Issue:6

    Topics: Animals; Antimalarials; Cytokines; Disease Models, Animal; Drug Synergism; Female; Heme Oxygenase-1; Inflammation; Lovastatin; Malaria, Cerebral; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oxidative Stress; Plasmodium berghei; Vascular Endothelial Growth Factor A

2015
Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria.
    PLoS pathogens, 2012, Volume: 8, Issue:12

    Topics: Animals; Brain; CD11b Antigen; Chemokines; Chloroquine; Cognition Disorders; Cytokines; Edema; Endothelium; Heme Oxygenase-1; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; Leukocytes; Lovastatin; Malaria, Cerebral; Membrane Proteins; Mice; Mice, Inbred C57BL; Oxidative Stress; Plasmodium berghei; RNA, Messenger

2012